0 Comentários
0 Compartilhamentos
3KB Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Biomarkers Market Size, Share & Growth Forecast 2026-2034According to The Insight Partners, The global Biomarkers Market size is projected to reach US$ 216.54 billion by 2034 from US$ 87.17 billion in 2025. The market is anticipated to register a CAGR of 10.64% during the forecast period 2026–2034. This growth reflects the increasing integration of biomarkers into clinical diagnostics, drug development, personalized medicine, and disease...0 Comentários 0 Compartilhamentos 34 Visualizações 0 Anterior
-
Biomarkers Market Size, Share, and Growth Forecast 2026–2033The Biomarkers Market is covered by Business Market Insights with 2025 as the base year and 2026–2033 as the forecast period. The retrieved public source material for this batch did not expose all three headline values required for a verified numerical opening, so no market-size figure or CAGR is inferred. Market growth is best understood through customer demand, operating economics, and...0 Comentários 0 Compartilhamentos 318 Visualizações 0 Anterior
-
Biomarkers Market to Grow at a CAGR of 13.36% Through 2032“According to a new report published by Introspective Market Research, Biomarkers Market by Type, Application, and End User, The Global Biomarkers Market Size Was Valued at USD 80.04 Billion in 2023 and is Projected to Reach USD 278.6 Billion by 2032, Growing at a CAGR of 13.36% from 2024–2032.” The biomarkers market plays a pivotal role in modern healthcare by enabling early...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Can New Biomarkers Like NGAL Transform the Acute Kidney Injury Treatment Market?Deep Dive: Acute Kidney Injury Treatment Market Dynamics (2025–2033) The global Acute Kidney Injury Treatment Market is currently undergoing a transformative era. As of early 2026, the sector has moved beyond simple fluid management into a sophisticated landscape of "smart" renal replacement and precision pharmacology. With the market projected to reach USD 8.2 billion by...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Cancer Biomarkers Market Graph: Growth, Share, Value, Insights, and Trends"Comprehensive Outlook on Executive Summary Cancer Biomarkers Market Market Size and Share CAGR Value Data Bridge Market Research analyses that the cancer biomarkers market, which was USD 13.24 billion in 2022, would rocket up to USD 36.74 billion by 2030 and is expected to undergo a CAGR of 13.6% during the forecast period from 2023 to 2030. This competitive era calls for...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Cardiac Biomarkers Testing Market Size, Share, Trends, Demand, Growth and Competitive OutlookCardiac Biomarkers Testing Market By Type (Myocardial muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA)), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis), Location of Testing (Point of Care, Laboratory) – Industry Trends and Forecast to...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Cardiac Biomarkers Testing Market Size, Share, Trends, Key Drivers, Growth and Opportunity AnalysisCardiac Biomarkers Testing Market By Type (Myocardial muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA)), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis), Location of Testing (Point of Care, Laboratory) – Industry Trends and...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Cardiac Biomarkers Testing Market: Diagnostic AdvancementsCardiac Biomarkers Testing Market Summary: According to the latest report published by Data Bridge Market Research, the Cardiac Biomarkers Testing Market CAGR Value Data Bridge Market Research analyses that the cardiac biomarkers testing market which is USD 12098.97 million in 2022, is expected to reach USD 28491.13 million by 2030, at a CAGR of 11.30% during the forecast period...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Genomic Biomarkers and Precision Oncology: A Fast-Growing Healthcare OpportunityThe Genomic Biomarkers Market is attracting attention as advances in genomic technologies create new opportunities for earlier disease identification and more individualized treatment planning. Genomic biomarkers can help researchers identify molecular signatures associated with specific conditions and assess potential differences in treatment response. Their use in oncology, drug development,...0 Comentários 0 Compartilhamentos 349 Visualizações 0 Anterior
-
Global Neurological Biomarkers Market Size, Share, Trends, Key Drivers, Demand and OpportunitiesExecutive Summary Neurological Biomarkers Market Size and Share: Global Industry Snapshot Data Bridge Market Research analyses that the neurological biomarkers market, which was USD 6.92 billion in 2022, would rise to USD 21.45 billion by 2030 and is expected to undergo a CAGR of 13.4% during the forecast period from 2023 to 2030. Businesses can depend with confidence upon this...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Increasing Use of Companion Diagnostics Drives Global Genomic Biomarkers IndustryThe growing use of genomic testing is transforming disease diagnosis and treatment strategies. Healthcare providers and pharmaceutical companies are increasingly using genomic biomarkers to understand disease mechanisms, identify suitable therapies, and evaluate treatment responses. In addition, advancements in next-generation sequencing, polymerase chain reaction technologies, and molecular...0 Comentários 0 Compartilhamentos 124 Visualizações 0 Anterior
-
Can plasma pTau217 detect amyloid and tau pathology in preclinical Alzheimer’s disease before cognitive decline begins?A study featured by Alamar Biosciences compared brain-derived pTau217 with total pTau217 in two cohorts characterized using amyloid PET. Brain-derived pTau217 showed strong performance in classifying amyloid pathology. It also performed better at identifying tau-positive individuals among those who were amyloid-positive. The findings support further research into pTau217 for identifying...0 Comentários 0 Compartilhamentos 732 Visualizações 0 Anterior
-
Cancer/Tumor Profiling Market Size Projected to Reach USD 23.4 Billion by 2032“According to a new report published by Introspective Market Research, Cancer/Tumor Profiling Market by Technology, Cancer Type, and Application, The Global Cancer/Tumor Profiling Market Size Was Valued at USD 11.08 Billion in 2024 and is Projected to Reach USD 23.4 Billion by 2032, Growing at a CAGR of 9.8%.” Cancer/Tumor Profiling refers to the comprehensive molecular examination...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Carcinoembryonic Antigen Market to Reach USD 3.16 Billion by 2033, Growing at 5.06% CAGRMarket Overview The global carcinoembryonic antigen market size was valued at USD 2.03 billion in 2024 And is projected to reach from USD 2.13 billion in 2025 to USD 3.16 billion by 2033, growing at a CAGR of 5.06% during the forecast period (2024–2032). The global Carcinoembryonic Antigen market continues to evolve rapidly, driven...0 Comentários 0 Compartilhamentos 6KB Visualizações 0 Anterior
-
Global Colorectal Cancer Treatment Market Advances with Targeted Therapies, Immunotherapy, and Early DiagnosisComprehensive Outlook on Executive Summary Colorectal Cancer Treatment Market Size and Share The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. The market is valued at USD 19 billion in 2022, and it would grow upto USD 26 billion by 2030. The insights provided in this Colorectal Cancer Treatment Market research...0 Comentários 0 Compartilhamentos 4KB Visualizações 0 Anterior
Páginas impulsionada